LB
34
8
ETR
68
3
DLTR
34
-4
CSCO
63
2
JNJ
41
2
NI
75
2
MCO
73
3
BAC
50
-3
ILMN
32
-3
IBM
54
4
CMCSA
48
2
NRG
49
-3
FOXA
55
9
PNW
66
3
NOV
58
3
VRTX
46
2
INTC
35
-2
COST
58
-2
FLS
73
-2
TRV
53
-3
LB
34
8
ETR
68
3
DLTR
34
-4
CSCO
63
2
JNJ
41
2
NI
75
2
MCO
73
3
BAC
50
-3
ILMN
32
-3
IBM
54
4
CMCSA
48
2
NRG
49
-3
FOXA
55
9
PNW
66
3
NOV
58
3
VRTX
46
2
INTC
35
-2
COST
58
-2
FLS
73
-2
TRV
53
-3
Financhill
Back

Colgate-Palmolive 10K Form

Buy
56

CL
Colgate-Palmolive

Last Price:
93.90
Seasonality Move:
2.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CL News And Ratings

See the #1 stock for the next 7 days that we like better than CL

CL Financial Statistics

Sales & Book Value

Annual Sales: $19.46B
Cash Flow: $1.03B
Price / Cash Flow: 22.94
Annual Sales: $0.53
Price / Book: 177.71

Profitability

EPS (TTM): 3.49000
Net Income (TTM): $2.87B
Gross Margin: $11.33B
Return on Equity: 434.96%
Return on Assets: 17.44%

Colgate-Palmolive Earnings Forecast

Key Colgate-Palmolive Financial Ratios

  • The Gross Profit Margin over the past 40 years for CL is 58.21%.
  • The Selling, General & Administrative Expenses for CL have been equal to 36.75% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 12.48% of Operating Income.
  • The Net Earning history of CL is 11.82% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 26 years.

Colgate-Palmolive Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Household Products
Sector: Consumer Staples
Current Symbol: CL
CUSIP: 194162
Website: colgatepalmolive.com

Debt

Debt-to-Equity Ratio: 19.39
Current Ratio: 1.04
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 34.16
Forward P/E Ratio: 24.5

CL Technical Analysis vs Fundamental Analysis

Buy
56
Colgate-Palmolive (CL) is a Buy

Is Colgate-Palmolive a Buy or a Sell?

  • Colgate-Palmolive stock is rated a Buy
    The current Colgate-Palmolive [CL] share price is $93.91. The Score for CL is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.